文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

ICU入住时肠道微生物组α多样性的临床与培养预测因素

Clinical and Culture-Based Predictors of Gut Microbiome Alpha Diversity at the Time of ICU Admission.
PubMed 文献 · Crit Care Explor · 2026-07-24
一句话结论在脓毒症ICU患者中,入住前所在病区、1年内感染史和VRE定植可预测肠道微生物Shannon多样性。

该研究为单中心随机临床试验的回顾性再分析,纳入90例以脓毒症为主要诊断、接受广谱抗生素且在入住ICU 24小时内可入组的患者。在入住ICU 24小时内采集深部直肠拭子,测序计算Shannon指数并培养VRE,按Shannon多样性三分位分组。多因素分析显示,入住ICU前所在位置(ICU转入 vs 急诊、病房 vs 急诊)、1年内培养证实的感染史以及入住时VRE阳性是预测低Shannon三分位的独立因素。该模型仅为初步框架,需在更大的独立队列中验证。

要点

  • 入住ICU前在病房 vs 急诊与低Shannon多样性相关(aOR 6.09,95%CI 1.89-19.6)。
  • 入住ICU前在ICU转入 vs 急诊与低Shannon多样性相关(aOR 3.54,95%CI 1.21-10.3)。
  • 1年内培养证实的感染史与低Shannon多样性相关(aOR 2.46,95%CI 1.02-5.96)。
  • 入住ICU时直肠拭子VRE阳性 vs 阴性与低Shannon多样性相关(aOR 4.18,95%CI 1.44-12.1)。

适用人群与场景

  • 以脓毒症为主要诊断、接受广谱抗生素、可在入住ICU 24小时内入组的ICU患者。
  • 单中心研究,排除标准原文未详细列出。

诊断标准与关键阈值

  • 原文未提及明确的诊断标准或阈值;α多样性以Shannon指数三分位(低、中、高)分组,主要结局为入住ICU时处于低Shannon三分位。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:随机临床试验(NCT03865706)的回顾性再分析;单中心;样本量90例脓毒症ICU患者。
  • 干预与对照:无干预;在入住ICU 24小时内采集深部直肠拭子进行测序(Shannon指数)和VRE培养。
  • 主要终点:入住ICU时处于低Shannon三分位;多因素分析显示入住前位置(ICU转入 vs 急诊 aOR 3.54,95%CI 1.21-10.3;病房 vs 急诊 aOR 6.09,95%CI 1.89-19.6)、1年内培养证实的感染(aOR 2.46,95%CI 1.02-5.96)、VRE阳性(aOR 4.18,95%CI 1.44-12.1)可描述α多样性的准线性趋势。
  • 关键次要终点和不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:单中心随机临床试验的回顾性再分析。
  • 证据等级或推荐强度:原文未提及。
  • 局限:单中心、回顾性再分析、样本量90例;模型为初步框架,需在更大的独立队列中验证。

对床旁实践的改变

  • 该模型提示入住ICU前所在病区、1年内感染史和VRE定植可辅助识别肠道微生物多样性较低的患者,但仅为初步框架,需外部验证,不能作为床旁决策阈值。
  • 适用人群:以脓毒症为主要诊断、接受广谱抗生素的ICU患者;不适用人群原文未提及。
  • 常见陷阱:原文未提及。

指南或共识出处

  • 原文未提及指南或共识出处;研究注册号NCT03865706。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: Microbiome-based therapies to improve gut colonization resistance are being developed for the ICU, but their efficacy may depend on the baseline gut microbiome at ICU admission. We sought to identify clinical predictors of alpha diversity at ICU admission.

DESIGN: Retrospective reanalysis of a randomized clinical trial (NCT03865706).

SETTING: Single-center ICU.

PATIENTS: ICU patients with sepsis as the primary diagnosis who were receiving broad-spectrum antibiotics and could be enrolled within 24 hours of ICU admission.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Demographic and clinical characteristics for medical ICU patients with sepsis were recorded during a previously published randomized clinical trial. Deep rectal swabs were collected within 24 hours of ICU admission and sequenced to describe alpha diversity (Shannon index) and cultured for vancomycin-resistant Enterococcus (VRE). Patients were organized into tertiles of Shannon diversity (low, middle, high) with a primary outcome of a lower Shannon tertile at ICU admission. Overall, 90 patients were enrolled. The three variables of location before ICU admission (adjusted odds ratio [aOR], 3.54; 95% CI, 1.21-10.3 for ICU transfer vs. emergency department [ED]; aOR, 6.09; 95% CI, 1.89-19.6 for hospital ward vs. ED), prior culture-proven infection within 1 year (aOR, 2.46; 95% CI, 1.02-5.96), and VRE status on ICU admission (aOR, 4.18; 95% CI, 1.44-12.1 for positive vs. negative swab) were sufficient to describe a quasi-linear trend in alpha diversity at ICU admission.

CONCLUSIONS: Baseline gut microbiome Shannon alpha diversity at ICU admission could be described with three readily ascertained clinical variables. Our model shows promise as a preliminary framework of factors that collectively best predict baseline alpha diversity at ICU admission and warrants validation in larger independent cohorts.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Ma D, Uhlemann AC, Abrams JA, et al. Clinical and Culture-Based Predictors of Gut Microbiome Alpha Diversity at the Time of ICU Admission. Crit Care Explor. 2026. PMID: 42497015. doi:10.1097/CCE.0000000000001455

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。